Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2001-1326
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack ; volume:8 ; number:1 ; day:4 ; month:3 ; year:2019 ; pages:1-4 ; date:12.2019
Clinical and translational medicine ; 8, Heft 1 (4.3.2019), 1-4, 12.2019
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40169-019-0223-z
- URN
-
urn:nbn:de:101:1-2019033001051577957969
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Khazaei, Mojtaba
- Ghasemian, Fateme
- Mazdeh, Mehrdokht
- Taheri, Mohammad
- Ghafouri-Fard, Soudeh
- SpringerLink (Online service)
Ähnliche Objekte (12)
![The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]](/assets/placeholder/searchResultMediaUnknown.png)
The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]
High On-Treatment Platelet Reactivity: Aspirin versus Clopidogrel
Aspirin Days (Aspirin days : )
Is clopidogrel superior to aspirin in secondary prevention of vascular disease?
Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy
Aspirin
Aspirin
Aspirin
Aspirin
Therapeutic applications of Aspirin
The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective
Combination of aspirin with essential fatty acids is superior to aspirin alone to prevent or ameliorate sepsis or ARDS
The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]
High On-Treatment Platelet Reactivity: Aspirin versus Clopidogrel
Aspirin Days (Aspirin days : )
Is clopidogrel superior to aspirin in secondary prevention of vascular disease?
Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy
Aspirin
Aspirin
Aspirin
Aspirin
Therapeutic applications of Aspirin
The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective
Combination of aspirin with essential fatty acids is superior to aspirin alone to prevent or ameliorate sepsis or ARDS
The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]
High On-Treatment Platelet Reactivity: Aspirin versus Clopidogrel
Aspirin Days (Aspirin days : )
Is clopidogrel superior to aspirin in secondary prevention of vascular disease?
Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy
Aspirin
Aspirin
Aspirin
Aspirin
Therapeutic applications of Aspirin
The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective